Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-((2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1h-inden-4-yl)oxy)-5-fluorobenzonitrile
2. Pt2385
1. Pt-2385
2. 1672665-49-4
3. Pt2385
4. 6o16716dxp
5. (s)-3-((2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1h-inden-4-yl)oxy)-5-fluorobenzonitrile
6. 3-[[(1s)-2,2-difluoro-1-hydroxy-7-methylsulfonyl-1,3-dihydroinden-4-yl]oxy]-5-fluorobenzonitrile
7. 3-(((1s)-2,2-difluoro-1-hydroxy-7-methanesulfonyl-2,3-dihydro-1hinden-4-yl)oxy)-5-fluorobenzonitrile
8. Benzonitrile, 3-(((1s)-2,2-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1h-inden-4-yl)oxy)-5-fluoro-
9. 79a
10. Unii-6o16716dxp
11. Chembl4173075
12. Schembl16555810
13. Bdbm373008
14. Ex-a2855
15. Us9896418, Compound 163
16. Nsc787312
17. S8352
18. Zb1597
19. Zinc230453533
20. Nsc-787312
21. Ncgc00387306-02
22. Ac-36340
23. Bs-16188
24. Hy-12867
25. D83665
26. A930106
27. Q27456687
| Molecular Weight | 383.3 g/mol |
|---|---|
| Molecular Formula | C17H12F3NO4S |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 383.04391352 g/mol |
| Monoisotopic Mass | 383.04391352 g/mol |
| Topological Polar Surface Area | 95.8 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 686 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
33
PharmaCompass offers a list of PT-2385 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right PT-2385 manufacturer or PT-2385 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred PT-2385 manufacturer or PT-2385 supplier.
PharmaCompass also assists you with knowing the PT-2385 API Price utilized in the formulation of products. PT-2385 API Price is not always fixed or binding as the PT-2385 Price is obtained through a variety of data sources. The PT-2385 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PT-2385 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PT-2385, including repackagers and relabelers. The FDA regulates PT-2385 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PT-2385 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A PT-2385 supplier is an individual or a company that provides PT-2385 active pharmaceutical ingredient (API) or PT-2385 finished formulations upon request. The PT-2385 suppliers may include PT-2385 API manufacturers, exporters, distributors and traders.
PT-2385 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PT-2385 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PT-2385 GMP manufacturer or PT-2385 GMP API supplier for your needs.
A PT-2385 CoA (Certificate of Analysis) is a formal document that attests to PT-2385's compliance with PT-2385 specifications and serves as a tool for batch-level quality control.
PT-2385 CoA mostly includes findings from lab analyses of a specific batch. For each PT-2385 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PT-2385 may be tested according to a variety of international standards, such as European Pharmacopoeia (PT-2385 EP), PT-2385 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PT-2385 USP).
